Graft-versus-host disease: symptoms and contacting the transplant team

After a donor stem cell transplant, new skin, digestive, eye or other symptoms should be discussed with the transplant team. Some may relate to graft-versus-host disease (GVHD), while others may have different causes. An information page cannot distinguish them. The priority is a clear route for assessment, especially when the patient has returned to another country.

Know the purpose of reporting symptoms

The NHS describes GVHD as a possible complication after transplantation using donor cells and notes that it can affect several organs. Reporting a symptom does not mean diagnosing GVHD yourself. It gives the team the opportunity to decide what examination or testing is needed.

Tell the team when a symptom began, how it has changed and how it affects eating, drinking, vision, breathing or movement. Include recent medicine changes and other relevant symptoms. Do not wait until the next scheduled review if the team’s instructions say to contact them earlier.

Separate routine contact from urgent assessment

Fever or signs of infection after transplantation need prompt contact with the care team. Severe breathing difficulty, significant chest pain or rapid deterioration require immediate local medical help. Do not use an international clinic’s routine message form as the only route for an urgent problem.

Before discharge, ask for written instructions that identify the transplant team’s urgent number and the local service to use if that team cannot be reached. Keep this information available to the accompanying person, with the transplant summary and current prescriptions.

Prepare a useful follow-up record

• Transplant date, donor-transplant summary and previous GVHD assessments, if any.
• The current medicine list and the prescriber responsible for each change.
• A dated symptom description and relevant examination or laboratory reports.
• Photos only if the team requests them through an appropriate clinical channel.
• The contact details of local specialists already involved.

Do not independently increase, reduce or stop immune-suppressing treatment in response to a symptom or laboratory result. If taking medicine has become difficult, report that promptly so the team can advise.

Make shared care explicit

For a patient treated in Turkey and followed at home, ask who coordinates assessments by the transplant team and any eye, skin, lung or other specialist. Clarify who receives reports and who communicates the combined plan. Several appointments do not automatically add up to coordinated care.

If a second opinion is sought, send the existing diagnosis and treatment-response history for GVHD, including any uncertainty. Confirm whether examination is required before travel is arranged. The current plan remains under the treating clinicians while that review is pending.

For practical planning, ask which consultations, tests and medicines are included in follow-up arrangements and how unscheduled assessments are organised. This guide supports symptom reporting and care coordination; it does not diagnose GVHD or recommend a treatment regimen.

A practical next step

For the practical arrangements, see Follow-up after bone marrow transplantation when returning home.

Sources

• NHS: Complications of a Stem Cell or Bone Marrow Transplant